Topic · learning objective · Audio
learning objective: audio
The 20 most recent episodes and tracks on this topic, about 7.8 hours of it.
Saves to your Listen queue, to pick up on another day or another device.
Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.
- Myasthenia Gravis Guidelines: A Global View for Local PracticeKeeping Current38:12Notes
- From Mechanism to Management: Applying Evidence for Hemophilia A in the ClinicKeeping Current18:01Notes
- Updating Our Checklist for Transthyretin Amyloid Cardiomyopathy MonitoringKeeping Current41:36Notes
- Mild Cognitive Impairment and Mild Dementia: Can We Act Before It's Too Late?Keeping Current39:21Notes
- Why Target APRIL in IgA Nephropathy Management? Get Up to Speed With the Mechanisms of Action and Key DataKeeping Current27:56Notes
- Beyond Intervals: The Next Era of Continuous Delivery in Retinal MedicineKeeping Current32:28Notes
- When and How Should I Optimize Heart Failure Treatments for My Patients?Keeping Current26:07Notes
- The Evolving Diagnostic and Management Landscape for Progressive Familial Intrahepatic CholestasisKeeping Current35:35Notes
- Pharmacological and Combination Interventions for Nicotine CessationKeeping Current33:24Notes
- Is Normalizing Hemostasis an Achievable Goal in Hemophilia A?Keeping Current29:31Notes
- Provek AI webinar - What's Changed What's Next What's at Stake - Oct 2025 - audioProvek podcasts42:38Notes
- Provek PFQ - LO3 - v3-MP3Provek podcasts11:07Notes
- Provek PFQ - LO9 - v3-MP3Provek podcasts9:47Notes
- Provek PFQ - LO10 - v3-MP3Provek podcasts22:24Notes
- Provek PFQ - LO8 - v3-MP3Provek podcasts9:08Notes
- Provek PFQ - Conclusion - v3-MP3Provek podcasts3:57Notes
- Provek PFQ - LO5 Part 1 - v3-MP3Provek podcasts10:48Notes
- Provek PFQ - LO7 - v3-MP3Provek podcasts16:31Notes
- Provek PFQ - LO6 Part 1 - v3-MP3Provek podcasts17:10Notes
- Provek PFQ - Introduction - v3-MP3Provek podcasts3:54Notes
This playlist:.m3u.plsAll the feeds behind it
